Literature DB >> 32285707

Therapeutic Effects of Curcumol in Several Diseases; An Overview.

Sheema Hashem1, Sabah Nisar1, Geetanjali Sageena2, Muzafar A Macha3,4, Santosh K Yadav1, Roopesh Krishnankutty5, Shahab Uddin5, Mohammad Haris1, Ajaz A Bhat1.   

Abstract

Curcumae Rhizoma, also known as Ezhu is a traditional Chinese medicine that has been used for many centuries against several diseases. The rhizome of the plant is composed of curcuminoids (curcumin, demethoxycurcumin, and bisdemethoxycurcumin), and essential volatile oils including curcumol, curdione, and germacrone. While curcuminoids have been extensively studied for their antimicrobial, antioxidant, anti-inflammatory and anticancer properties, the therapeutic efficacy of curcumol is still emerging. Recent studies have shown anticancer properties of curcumol against multiple solid tumors such as breast, colorectal, head and neck, and lung adenocarcinomas. The underlying anti-tumor mechanisms revealed inhibition of several signaling pathways (NF-κB, MAPK, PI-3K/AKT, and GSK-3β) associated with cell proliferation, survival, anti-apoptosis, invasion and metastasis. Besides curcumol, extracts from the Curcumae Rhizoma roots possess many other terpenoids such as β-elemene, δ-elemene, germacrone, furanodiene and furanodienone with known anticancer properties. In this review, we comprehensively focused on the composition of Curcumae Rhizoma essential oils, their structure, isolation and therapeutic uses of curcumol to aid in the improvement and development of novel drugs with minimal cytotoxicity, enhanced efficacy, and less cost.

Entities:  

Keywords:  Antioxidant; apoptosis; cancer prevention; dietary intervention; oxidative stress; transcription factors

Year:  2020        PMID: 32285707     DOI: 10.1080/01635581.2020.1749676

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  9 in total

1.  Curcumol Suppresses CCF-Mediated Hepatocyte Senescence Through Blocking LC3B-Lamin B1 Interaction in Alcoholic Fatty Liver Disease.

Authors:  Xiaoyu Qi; Shuguo Zheng; Mingyue Ma; Naqi Lian; Hongting Wang; Lerong Chen; Anping Song; Chunfeng Lu; Shizhong Zheng; Huanhuan Jin
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

2.  Microsatellite Status and IκBα Expression Levels Predict Sensitivity to Pharmaceutical Curcumin in Colorectal Cancer Cells.

Authors:  Lili Lu; Randy Przybylla; Yuru Shang; Meng Dai; Mathias Krohn; Oliver Holger Krämer; Christina Susanne Mullins; Michael Linnebacher
Journal:  Cancers (Basel)       Date:  2022-02-17       Impact factor: 6.639

Review 3.  Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates.

Authors:  Abdelhakim Bouyahya; Naoufal El Hachlafi; Tarik Aanniz; Ilhame Bourais; Hamza Mechchate; Taoufiq Benali; Mohammad Ali Shariati; Pavel Burkov; José M Lorenzo; Polrat Wilairatana; Mohammad S Mubarak; Nasreddine El Omari
Journal:  Molecules       Date:  2022-04-15       Impact factor: 4.927

4.  Network Pharmacology-Based Approach Combined with Bioinformatic Analytics to Elucidate the Potential of Curcumol against Hepatocellular Carcinoma.

Authors:  Xufeng Huang; Hafiz Muzzammel Rehman; Attila Gábor Szöllősi; Shujing Zhou
Journal:  Genes (Basel)       Date:  2022-04-07       Impact factor: 4.141

5.  Curcumol inhibits the viability and invasion of colorectal cancer cells via miR-30a-5p and Hippo signaling pathway.

Authors:  Dan Yu; Haiping Liu; Jianli Qin; Mengjie Huangfu; Xiao Guan; Xumei Li; Luwei Zhou; Tong Dou; Yisa Liu; Lin Wang; Minglei Fu; Juan Wang; Xu Chen
Journal:  Oncol Lett       Date:  2021-02-17       Impact factor: 2.967

6.  Curdione Induces Antiproliferation Effect on Human Uterine Leiomyosarcoma via Targeting IDO1.

Authors:  Chao Wei; Donghua Li; Yu Liu; Wenna Wang; Tiantian Qiu
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

7.  Combinative treatment of Curdione and docetaxel triggers reactive oxygen species (ROS)-mediated intrinsic apoptosis of triple-negative breast cancer cells.

Authors:  Changcheng Wang; Jia Guo; Zeng'An Wu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  Curcumol Inhibits the Development of Prostate Cancer by miR-125a/STAT3 Axis.

Authors:  Wen Sheng; Jin Ding; Lumei Liu; Neng Wang; Baowei Lu; Xujun You; Qinghu He; Qing Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-30       Impact factor: 2.650

9.  Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages.

Authors:  Jincheng Wang; Jialu Jin; Ting Chen; Qian Zhou
Journal:  Molecules       Date:  2022-07-06       Impact factor: 4.927

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.